NCT02375217View on ClinicalTrials.gov

"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Anesthesia Recovery
Interventions
DRUG

Sugammadex

half dose

DRUG

Sugammadex

full dose

DRUG

Neostigmine

IV = 50mcg/kg

DRUG

glycopyrrolate

Trial Locations (1)

Unknown

AUBMC, Beirut

All Listed Sponsors
lead

American University of Beirut Medical Center

OTHER

NCT02375217 - "Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy" | Biotech Hunter | Biotech Hunter